Zobrazeno 1 - 10
of 101
pro vyhledávání: '"J Necciari"'
Autor:
Pierre Sie, J Necciari, C Gaud, H Caplain, J. P. Duret, Bernard Boneu, P. d’Azemar, C. Navarro, J P Cambus
Publikováno v:
Thrombosis and Haemostasis. 79:338-341
SummaryVenous thromboembolism may be efficiently treated by once-a-day (o.d.) administration of a high dose of low molecular weight heparin (LMWH) instead of administration of the same total dose in two injections a day (b.i. d.). To reduce the volum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::046bcc591b8d00020e4b9a87cb55f663
https://doi.org/10.1055/s-0037-1614988
https://doi.org/10.1055/s-0037-1614988
Autor:
J. Necciari, P. Zandberg, R. Cariou, R. G. M. Van Amsterdam, Petitou Maurice, D.G. Meuleman, H.N. Magnani, J. M. Herbert, Jean-C. Lormeau, C. A. A. Van Boeckel
Publikováno v:
Cardiovascular Drug Reviews. 15:1-26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7645a36348d9a7ba3c639d19ce3d4f79
https://doi.org/10.1111/j.1527-3466.1997.tb00321.x
https://doi.org/10.1111/j.1527-3466.1997.tb00321.x
Publikováno v:
Bone. 17:S479-S483
Tiludronate is a bisphosphonate evaluated extensively as an osteoregulator in the treatment of metabolic bone disorders. It is highly polar and has a low and variable oral absorption similar to its related compounds. An absolute bioavailability of ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e1e1f6eddb9fd5888fda761f34336b4
https://doi.org/10.1016/8756-3282(95)00259-6
https://doi.org/10.1016/8756-3282(95)00259-6
Publikováno v:
Journal of Pharmaceutical Sciences. 83:1461-1464
The pharmacokinetics of valproic acid after oral administration of sustained-release formulations were studied in 12 healthy volunteers. The objective of the present study was to find an appropriate mathematical model to describe the complex drug int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0176c7b312d3a4b59aafbc7486544926
https://doi.org/10.1002/jps.2600831019
https://doi.org/10.1002/jps.2600831019
Autor:
Y. Berger, G. Kieffer, Jean-Pierre Maffrand, G. Defreyn, E. Vallee, Jean-Marc Herbert, J. Necciari, D. Gouy, D. Frehel
Publikováno v:
Cardiovascular Drug Reviews. 11:180-198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12a12bc84de1c73c25ef97283124a517
https://doi.org/10.1111/j.1527-3466.1993.tb00275.x
https://doi.org/10.1111/j.1527-3466.1993.tb00275.x
Publikováno v:
Journal of Cardiovascular Pharmacology. 16:S31-S37
Among the antihypertensive agents, calcium antagonists and in particular diltiazem play a leading role. To improve the conditions of diltiazem administration in the treatment of hypertensive patients a galenic formulation allowing administration of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::623a640308da62c3196a7e0e5f3a323b
https://doi.org/10.1097/00005344-199000161-00007
https://doi.org/10.1097/00005344-199000161-00007
Publikováno v:
Seminars in thrombosis and hemostasis. 25
Two open, randomized, crossover bioavailability studies were carried out to assess the influence of concurrent antacid medication and food on the bioavailability of clopidogrel. A fed/fasting study was conducted in 12 elderly male subjects. Each subj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::21ebf33da12da9eaf3b4419007d07934
https://pubmed.ncbi.nlm.nih.gov/10440423
https://pubmed.ncbi.nlm.nih.gov/10440423
Publikováno v:
Seminars in thrombosis and hemostasis. 25
In order to obtain a global assessment of circulating clopidogrel-related products and of the excretion of the drug, the pharmacokinetic behavior and the excretion balance of 14C radioactivity following the administration of a single dose of 75 mg of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::07b551e65db176d0f22e0523f52c82df
https://pubmed.ncbi.nlm.nih.gov/10440420
https://pubmed.ncbi.nlm.nih.gov/10440420
Autor:
C H, Pierce, J M, Houle, J P, Dickinson, M, Kindermans, E, Serre-Lacroix, G, Kieffer, J, Necciari
Publikováno v:
Seminars in thrombosis and hemostasis. 25
The influence of clopidogrel 75 mg, given once daily for 10 days on hepatic P-450 mixed function oxidases, was examined by assessing its effect on the disposition of antipyrine, on urinary 6-betahydroxycortisol (6beta-OHC) and on the plasma activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ca50e9ca2c1c1ab94e045cd67311ce38
https://pubmed.ncbi.nlm.nih.gov/10440421
https://pubmed.ncbi.nlm.nih.gov/10440421
Publikováno v:
Seminars in thrombosis and hemostasis. 25
The safety, and the pharmacodynamic and pharmacokinetic compatibility of clopidogrel, 75 mg daily, with the cardiac glycoside digoxin, were assessed in 12 healthy male subjects who took digoxin 0.25 mg once daily for 20 days and, in addition, clopido
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::19b747e9deebdd14ad6753e3c4bfc0ca
https://pubmed.ncbi.nlm.nih.gov/10440424
https://pubmed.ncbi.nlm.nih.gov/10440424